Leidos Holdings, Inc. (LDOS) Stock Analysis and Metrics

Leidos Holdings

NYSE: LDOS

$112.17 ▲ +1.84 (+1.67%)

At close: Jul 24, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap13.88 Bn

P/E9.71

P/S0.80

Div. Yield0.02

ROIC (Qtr)0.04

Total Debt (Qtr)6.33 Bn

Revenue Growth (1y) (Qtr)3.65

Add ratio to table…

About

Leidos Holdings, Inc. is a holding company whose principal operating subsidiary Leidos Inc delivers science research and engineering solutions to address complex problems of global concern. Founded in 1969 by physicist Dr Robert Beyster the company is headquartered in Reston Virginia and employs approximately 47000 people worldwide. Leidos serves federal government agencies and commercial customers by providing technology enabled services software products and integrated systems across five growth pillars space and maritime energy infrastructure digital modernization and cyber mission software and managed health services. The firm applies expertise in multiple disciplines to securely deliver solutions that meet current mission goals and support future objectives.

Leidos generates revenue primarily through contracts with the United States government which accounted for about 87 percent of total revenue in fiscal 2025 while approximately 8 percent came from entities located outside the United States. The company offers a wide array of services including digital modernization and transformation mission software multi domain solutions cyber operations intelligence analysis mission support and global logistics managed health services transportation solutions health mission software energy and environment life sciences research and development energy infrastructure global security products and services and defense systems spanning space airborne land and maritime domains. These services are delivered under various contract types such as cost reimbursement time and materials fixed price and firm fixed price arrangements.

The company operates through the following segments National Security & Digital Health & Civil Commercial & International and Defense Systems.

• National Security & Digital provides leading edge services solutions and products to substantially all U S federal government customers. Its capabilities include digital modernization and transformation which designs develops implements protects and maintains IT environments to deliver stability security and flexibility for mission needs. It also offers mission software that uses artificial intelligence tools for defense intelligence and homeland security customers. Multi domain solutions employ artificial intelligence and machine learning to coordinate sea ground air and space operations and provide warfighters with timely information for mission advantage. Cyber operations deliver full spectrum cyber solutions including offensive defensive and physical cyber operations and global scale cryptographic management to protect critical information and assets. Intelligence analysis mission support and global logistics services supply intelligence analysis operational support logistics security linguistics force production biometrics chemical biological radiological nuclear and explosives energetics training and other services to Intelligence Community customers.

• Health & Civil delivers services and solutions to federal and commercial customers in the areas of public health care coordination life and environment sciences and transportation. Its core capabilities include managed health services which deploys a national footprint of health clinics and providers to support care delivery including medical disability and behavioral health examinations for the Department of Veterans Affairs and other independent medical exam markets. Transportation Solutions provides air traffic control systems and automation services to air navigation service providers worldwide including the Federal Aviation Administration. Health Mission Software supplies a single common electronic health record to Department of War and Veterans Affairs hospitals and treatment facilities worldwide. Energy and Environment supports the missions of the Department of Energy National Nuclear Security Administration and National Science Foundation through infrastructure management operation information technology support applied research and education outreach. Life Sciences Research and Development provides research and development support to the National Institutes of Health Centers for Disease Control Army Medical Research community and commercial biotechnology companies through leading edge laboratories in genetics genomics proteins proteomics advanced biomedical computing information technology biopharmaceutical development manufacturing nanotechnology characterization and clinical trials management.

• Commercial & International delivers a portfolio of products services and solutions aimed at securing national assets modernizing energy and critical infrastructure and enhancing mission outcomes. Its key customers include Investor Owned Utilities government agencies in the United Kingdom and Australia the Transportation Security Administration U S Customs and Border Protection as well as airports ports and borders authorities. Energy Infrastructure partners with utilities seeking reliable energy modernization solutions and supports electric utilities generation owners and industrial clients in modernizing power delivery systems implementing energy management strategies advancing vehicle electrification transforming digital infrastructure and optimizing operational efficiency. Global Security Products and Services provides fully integrated security detection solutions that enhance the safety of screening and checkpoints for aviation ports borders and critical infrastructure worldwide with more than 30000 products deployed across over 120 countries including people scanners computed tomography carry on baggage scanners checked baggage scanners and explosive trace detectors. It also serves as the primary supplier to U S Customs and Border Protection and other international customers of mobile non intrusive ports and borders inspection systems that secure the flow of travel and trade by detecting and mitigating threats across cargo vehicles and individuals. International delivers mission focused services across multiple domains to address critical threats and provide innovative solutions to government agencies in the United Kingdom and Australia with core expertise in digital modernization mission software logistics and airborne solutions.

• Defense Systems addresses threats facing the nation by rapidly prototyping and delivering advanced hardware software and integrated systems solutions for the Department of War Army Navy Air Force Space Force Marine Corps United States Special Operations Command Defense Advanced Research Projects Agency and intelligence agencies. Its operations span the space airborne land and maritime domains. Maritime Systems provides innovative platforms software solutions for vessel control and common core autonomous behaviors enhanced sensor systems advanced signal processing secure communications hardware and software to support surface and subsurface autonomous and unmanned maritime operations. Aerospace Systems supplies expertise in the design manufacturing and integration of space based electro optic infrared multi hyperspectral electronic warfare signals intelligence and communications payloads and manufactures structures and thermal protection systems for hypersonic boost glide missiles while providing testing services for hypersonic vehicles. Land Systems develops integrated air and missile defense systems including the Army Enduring Indirect Fire Protection Capability Army Long Range Persistent Surveillance radar capability and AirShield systems and designs and manufactures other persistent surveillance radar systems advanced sensors and radio frequency seekers with associated advanced algorithms to provide military sensor and electronic system research and development services. Airborne Systems develops and integrates mission enhancing airborne solutions executing airborne training intelligence surveillance and reconnaissance missions as a service for the Department of War the U S Intelligence Community and military services worldwide with key served markets in aircraft integration and operations sensor and autonomous systems and multi domain operation enablers addressing diverse missions such as target identification border security and counter narcotics operations.

Leidos holds a strong position as an industry and technology leader in the government services and aerospace and defense sectors. The company competes with large established firms such as Accenture Federal Services LLC Amentum Services Inc KBR Inc BAE Systems Booz Allen Hamilton Inc CACI International Inc Deloitte General Dynamics Corporation GovCIO IBM L3Harris Technologies Inc Lockheed Martin Corporation ManTech Northrop Grumman Corporation Optum Parsons Corporation Peraton Inc RTX Corporation SAIC and many smaller specialized contractors. Its competitive advantages stem from a proven track record of delivering mission critical solutions deep expertise in science research and engineering robust cybersecurity and compliance practices a reliable supply chain effective data management and the ability to integrate commercial technologies and artificial intelligence at scale. Leidos also benefits from a workforce with high levels of security clearances and a focus on mission understanding and qualified staff retention.

Leidos customer base is heavily weighted toward United States government agencies with the majority of revenue derived from prime contracts or subcontracts for the Department of War the Intelligence Community the Department of Homeland Security the Federal Aviation Administration the Department of Veterans Affairs the Department of Health and Human Services the National Science Foundation the Department of Energy the Environmental Protection Agency the Defense Advanced Research Projects Agency and the Intelligence Advanced Research Projects Agency. International customers include the United Kingdom Ministry of Defence the Australian Department of Defence NATO and various commercial entities such as Investor Owned Utilities airports ports and borders authorities and the Transportation Security Administration and U S Customs and Border Protection. The company also serves a range of state and local government agencies and foreign government bodies across its diversified contract portfolio.

Investment Thesis

▲ Bull case

Leidos' NorthStar 2030 growth strategy is accelerating beyond initial expectations, with recent contract awards revealing a significant and underappreciated pipeline of high-margin, production-scale opportunities in hypersonics and low-cost munitions that are poised to transform revenue predictability and cash conversion. The $2.7 billion Army hypersonic weapons contract integrates the Thermal Protection Shield and Common Hypersonic Glide Body programs, moving beyond prototyping to full production, while the $1.5 billion framework agreement for Low-Cost Containerized Munitions (LCCM) builds directly on the proven AGM-190A SCM technology with plans for workforce expansion in Huntsville and McEwen to support production beginning in 2027. These initiatives leverage Leidos' established expertise in guidance systems, sensor technologies, and scalable production approaches, positioning the company as a critical enabler of the Department of War's 'Arsenal of Freedom' initiative. Unlike typical R&D-heavy defense contracts, these awards feature compressed development timelines and near-term revenue recognition, with LCCM's modular design enabling rapid integration across ground, maritime, and air-launched variants. The combination of these contracts creates a self-reinforcing growth loop where successful production drives follow-on orders for iterations and derivatives, directly supporting Leidos' claim of a path to thousands of SCM-derived products this decade and a refreshed $10 billion order pipeline in energy infrastructure post-Entrust acquisition. This production-scale focus in Defense Tech represents a structural shift from the company's traditional services-heavy mix, with the potential to elevate margins and reduce reliance on lengthy government procurement cycles.
The Homeland segment, often overlooked due to near-term margin pressure from the Entrust acquisition integration, is emerging as a hidden catalyst for multi-year growth through Leidos' expanded role in modernizing U.S. diplomatic IT infrastructure via the State Department's Evolve contract. Leidos secured awards across four functional categories—cloud and data center services, application development, network and telecommunications, and customer support—under this indefinite delivery/indefinite quantity contract with a $10 billion ceiling, directly advancing the NorthStar 2030 pillar of digital modernization and AI-driven operations. This win is particularly significant because it leverages Leidos' privileged access to federal digital ecosystems, a core competitive advantage highlighted by management as being amplified rather than disrupted by AI. The Evolve contract provides a scalable platform for deploying Leidos' Uphold, Insight, Forward, and Headway product suites, which strengthen its position as the trusted integrator of AI-enabled mission systems. Unlike transactional defense contracts, this diplomatic modernization effort offers recurring revenue streams from continuous monitoring, zero trust security implementation, and global network modernization—services that align with Leidos' strength in delivering open, secure, repeatable, and mission-critical solutions. The contract's structure also reduces customer acquisition cost over time, as Leidos becomes embedded in the State Department's long-term IT roadmap, creating sticky relationships that are less susceptible to budgetary volatility than traditional defense programs. This represents a structural expansion into adjacent federal markets where Leidos' trust-based relationships and regulatory expertise provide durable competitive moats.
Leidos' capital allocation strategy is creating asymmetric upside potential through disciplined deployment of excess cash flow into high-return ventures that are not fully reflected in current guidance, particularly the $100 million multiyear investment in a marquee private equity firm focused on federal technology disruptors. This venture-stage initiative provides early access to a vetted pipeline of high-growth companies in AI, advanced cyber, and autonomy—areas directly complementary to Leidos' growth pillars—while maintaining balance sheet flexibility through the SES joint venture with Analogic, which allows participation in Homeland Security upside without consuming Leidos' capital. The company's ability to generate $301 million in Q1 operating cash flow despite integration costs from Entrust demonstrates exceptional cash conversion strength, with free cash flow of $270 million and a robust gross leverage ratio of 2.6x providing ample capacity for strategic investments. Crucially, management's comment that they 'don't spend money just because we budgeted it' on CapEx reveals a culture of fiscal discipline where funds are deployed only when clear triggers emerge, suggesting that unanticipated opportunities like the LCCM framework agreement or Evolve awards could accelerate capital deployment beyond current plans. This approach minimizes the risk of overinvestment while positioning Leidos to capitalize on emerging technologies through both organic innovation and strategic stakes in disruptors, creating a dual-engine growth model that the market is underestimating by focusing solely on organic revenue guidance raises.

Leidos' NorthStar 2030 growth strategy is accelerating beyond initial expectations, with recent contract awards revealing a significant and underappreciated pipeline of high-margin, production-scale opportunities in hypersonics and low-cost munitions that are poised to transform revenue predictability and cash conversion. The $2.7 billion Army hypersonic weapons contract integrates the Thermal Protection Shield and Common Hypersonic Glide Body programs, moving beyond prototyping to full production, while the $1.5 billion framework agreement for Low-Cost Containerized Munitions (LCCM) builds directly on the proven AGM-190A SCM technology with plans for workforce expansion in Huntsville and McEwen to support production beginning in 2027. These initiatives leverage Leidos' established expertise in guidance systems, sensor technologies, and scalable production approaches, positioning the company as a critical enabler of the Department of War's 'Arsenal of Freedom' initiative. Unlike typical R&D-heavy defense contracts, these awards feature compressed development timelines and near-term revenue recognition, with LCCM's modular design enabling rapid integration across ground, maritime, and air-launched variants. The combination of these contracts creates a self-reinforcing growth loop where successful production drives follow-on orders for iterations and derivatives, directly supporting Leidos' claim of a path to thousands of SCM-derived products this decade and a refreshed $10 billion order pipeline in energy infrastructure post-Entrust acquisition. This production-scale focus in Defense Tech represents a structural shift from the company's traditional services-heavy mix, with the potential to elevate margins and reduce reliance on lengthy government procurement cycles.
The Homeland segment, often overlooked due to near-term margin pressure from the Entrust acquisition integration, is emerging as a hidden catalyst for multi-year growth through Leidos' expanded role in modernizing U.S. diplomatic IT infrastructure via the State Department's Evolve contract. Leidos secured awards across four functional categories—cloud and data center services, application development, network and telecommunications, and customer support—under this indefinite delivery/indefinite quantity contract with a $10 billion ceiling, directly advancing the NorthStar 2030 pillar of digital modernization and AI-driven operations. This win is particularly significant because it leverages Leidos' privileged access to federal digital ecosystems, a core competitive advantage highlighted by management as being amplified rather than disrupted by AI. The Evolve contract provides a scalable platform for deploying Leidos' Uphold, Insight, Forward, and Headway product suites, which strengthen its position as the trusted integrator of AI-enabled mission systems. Unlike transactional defense contracts, this diplomatic modernization effort offers recurring revenue streams from continuous monitoring, zero trust security implementation, and global network modernization—services that align with Leidos' strength in delivering open, secure, repeatable, and mission-critical solutions. The contract's structure also reduces customer acquisition cost over time, as Leidos becomes embedded in the State Department's long-term IT roadmap, creating sticky relationships that are less susceptible to budgetary volatility than traditional defense programs. This represents a structural expansion into adjacent federal markets where Leidos' trust-based relationships and regulatory expertise provide durable competitive moats.
Leidos' capital allocation strategy is creating asymmetric upside potential through disciplined deployment of excess cash flow into high-return ventures that are not fully reflected in current guidance, particularly the $100 million multiyear investment in a marquee private equity firm focused on federal technology disruptors. This venture-stage initiative provides early access to a vetted pipeline of high-growth companies in AI, advanced cyber, and autonomy—areas directly complementary to Leidos' growth pillars—while maintaining balance sheet flexibility through the SES joint venture with Analogic, which allows participation in Homeland Security upside without consuming Leidos' capital. The company's ability to generate $301 million in Q1 operating cash flow despite integration costs from Entrust demonstrates exceptional cash conversion strength, with free cash flow of $270 million and a robust gross leverage ratio of 2.6x providing ample capacity for strategic investments. Crucially, management's comment that they 'don't spend money just because we budgeted it' on CapEx reveals a culture of fiscal discipline where funds are deployed only when clear triggers emerge, suggesting that unanticipated opportunities like the LCCM framework agreement or Evolve awards could accelerate capital deployment beyond current plans. This approach minimizes the risk of overinvestment while positioning Leidos to capitalize on emerging technologies through both organic innovation and strategic stakes in disruptors, creating a dual-engine growth model that the market is underestimating by focusing solely on organic revenue guidance raises.

▼ Bear case

Leidos' reported revenue growth is increasingly dependent on acquisitions rather than organic performance, with the company masking underlying weakness in its core businesses through aggressive M&A activity that may not deliver promised synergies and could strain integration capacity. While total revenue rose 4% year-over-year in Q1 FY26, organic growth was only 3%, driven primarily by the Intelligence & Digital segment (6% organic) and Homeland (5.6% organic), while Defense showed minimal growth at 0.5% organic and Health was flat. This divergence is concerning because the Defense segment, which includes the high-profile hypersonic and munitions wins discussed by management, failed to translate contract awards into meaningful top-line expansion, suggesting potential execution delays or pricing pressure in these programs. The company's reliance on acquisitions to boost growth is evident in the $22 million Kudu contribution to Intelligence & Digital and the $11 million Entrust contribution to Homeland—without these, organic growth would have been significantly lower. More troubling is the declining profitability in Homeland, where reported operating income margin fell to 4.0% from 7.9% year-over-year, and non-GAAP margin decreased to 8.5% from 9.4%, primarily attributed to costs associated with the Entrust acquisition and the pending Security Products joint venture with Analogic. This margin compression raises questions about whether Leidos can successfully integrate Entrust while maintaining historical profitability levels, especially given management's own acknowledgment that Q2 may be a 'low point' due to pull-forward effects from Q1 and the absence of the $15 million insurance reimbursement that boosted Q1 results. The integration risk is compounded by the company's simultaneous pursuit of multiple large-scale initiatives—hypersonic production, LCCM scaling, Evolve IT modernization, and the SES JV—potentially overextending management attention and operational bandwidth during a period when government procurement remains recovering from protracted delays.
Leidos' Health segment, despite management's optimistic framing, faces structural headwinds that could precipitate a multi-year revenue and margin reset rather than the temporary dip suggested by leadership, particularly as the Veterans Benefits Administration (VBA) exam business shows signs of fundamental shift beyond cyclical backlog fluctuations. While management highlighted strong volume in Q1 and pointed to an upcoming industry day as a positive catalyst, the segment's revenue was flat year-over-year and operating income margin declined to 23.9% from 24.2%, with non-GAAP margin down to 24.2% from 24.7%. More critically, the company's reliance on fixed-price, fixed-unit-rate contracts in Health creates vulnerability to cost inflation and limits pricing power, a dynamic that could worsen if the VBA transitions toward value-based care or bundled payments models—trends already emerging in broader healthcare that management did not adequately address when questioned about long-term margin sustainability. The Military OneSource and My Service Treatment Record awards, while innovative, represent early-stage pilots with uncertain scalability; the latter remains in pilot phase with no clear path to becoming a 'very nice technology-oriented high revenue and profit stream' as management speculated. Furthermore, Leidos' emphasis on expanding into rural health and behavioral health, while strategically sound, requires significant upfront investment in technology and business model innovation that may not yield immediate returns, potentially dragging on segment profitability during the investment phase. The segment's ability to maintain its historical 20%+ margin threshold is questionable given these headwinds, especially as competitors increasingly leverage AI to automate administrative functions in veterans' services, eroding Leidos' traditional advantages in process efficiency and customer intimacy.
Leidos' growing dependence on AI as a margin accelerator is creating an unaddressed vulnerability where the very tools meant to enhance efficiency could accelerate commoditization of its core services, particularly in the Intelligence & Digital and Digital Infrastructure businesses where barriers to entry are lower than in cleared defense work. While management correctly notes that AI does not obsolete 'hard to get' elements like security clearances and regulatory access, they significantly understate the risk that AI-powered automation is rapidly reducing the time and cost to deliver routine development, basic analytics, and data integration—services that constitute a growing portion of Leidos' offerings in segments like Insight (Secure Cloud and data) and Forward (customer digital experience). This compression of the solution value chain, while beneficial for speed, increases price sensitivity among customers who can now obtain similar outputs from lower-cost providers or even in-house teams using generative AI tools, especially as federal agencies build their own AI capabilities. The company's privileged access to customer digital infrastructure, touted as a defense against AI disruption, may become less relevant as agencies adopt zero-trust architectures and cloud-native solutions that reduce reliance on legacy system integrators. Furthermore, the rising importance of AI in national security is attracting new entrants—including large tech firms and specialized AI startups—who are better positioned to innovate at the forefront of machine learning applications, potentially leapfrogging Leidos in areas like predictive maintenance or autonomous decision support where the company's current advantages in legacy system knowledge matter less. This dynamic threatens to erode Leidos' pricing power and market share in its fastest-growing segments over time, turning what management views as a propellant into a long-term competitive pressure that could force sustained investment just to maintain parity.

Leidos' reported revenue growth is increasingly dependent on acquisitions rather than organic performance, with the company masking underlying weakness in its core businesses through aggressive M&A activity that may not deliver promised synergies and could strain integration capacity. While total revenue rose 4% year-over-year in Q1 FY26, organic growth was only 3%, driven primarily by the Intelligence & Digital segment (6% organic) and Homeland (5.6% organic), while Defense showed minimal growth at 0.5% organic and Health was flat. This divergence is concerning because the Defense segment, which includes the high-profile hypersonic and munitions wins discussed by management, failed to translate contract awards into meaningful top-line expansion, suggesting potential execution delays or pricing pressure in these programs. The company's reliance on acquisitions to boost growth is evident in the $22 million Kudu contribution to Intelligence & Digital and the $11 million Entrust contribution to Homeland—without these, organic growth would have been significantly lower. More troubling is the declining profitability in Homeland, where reported operating income margin fell to 4.0% from 7.9% year-over-year, and non-GAAP margin decreased to 8.5% from 9.4%, primarily attributed to costs associated with the Entrust acquisition and the pending Security Products joint venture with Analogic. This margin compression raises questions about whether Leidos can successfully integrate Entrust while maintaining historical profitability levels, especially given management's own acknowledgment that Q2 may be a 'low point' due to pull-forward effects from Q1 and the absence of the $15 million insurance reimbursement that boosted Q1 results. The integration risk is compounded by the company's simultaneous pursuit of multiple large-scale initiatives—hypersonic production, LCCM scaling, Evolve IT modernization, and the SES JV—potentially overextending management attention and operational bandwidth during a period when government procurement remains recovering from protracted delays.
Leidos' Health segment, despite management's optimistic framing, faces structural headwinds that could precipitate a multi-year revenue and margin reset rather than the temporary dip suggested by leadership, particularly as the Veterans Benefits Administration (VBA) exam business shows signs of fundamental shift beyond cyclical backlog fluctuations. While management highlighted strong volume in Q1 and pointed to an upcoming industry day as a positive catalyst, the segment's revenue was flat year-over-year and operating income margin declined to 23.9% from 24.2%, with non-GAAP margin down to 24.2% from 24.7%. More critically, the company's reliance on fixed-price, fixed-unit-rate contracts in Health creates vulnerability to cost inflation and limits pricing power, a dynamic that could worsen if the VBA transitions toward value-based care or bundled payments models—trends already emerging in broader healthcare that management did not adequately address when questioned about long-term margin sustainability. The Military OneSource and My Service Treatment Record awards, while innovative, represent early-stage pilots with uncertain scalability; the latter remains in pilot phase with no clear path to becoming a 'very nice technology-oriented high revenue and profit stream' as management speculated. Furthermore, Leidos' emphasis on expanding into rural health and behavioral health, while strategically sound, requires significant upfront investment in technology and business model innovation that may not yield immediate returns, potentially dragging on segment profitability during the investment phase. The segment's ability to maintain its historical 20%+ margin threshold is questionable given these headwinds, especially as competitors increasingly leverage AI to automate administrative functions in veterans' services, eroding Leidos' traditional advantages in process efficiency and customer intimacy.
Leidos' growing dependence on AI as a margin accelerator is creating an unaddressed vulnerability where the very tools meant to enhance efficiency could accelerate commoditization of its core services, particularly in the Intelligence & Digital and Digital Infrastructure businesses where barriers to entry are lower than in cleared defense work. While management correctly notes that AI does not obsolete 'hard to get' elements like security clearances and regulatory access, they significantly understate the risk that AI-powered automation is rapidly reducing the time and cost to deliver routine development, basic analytics, and data integration—services that constitute a growing portion of Leidos' offerings in segments like Insight (Secure Cloud and data) and Forward (customer digital experience). This compression of the solution value chain, while beneficial for speed, increases price sensitivity among customers who can now obtain similar outputs from lower-cost providers or even in-house teams using generative AI tools, especially as federal agencies build their own AI capabilities. The company's privileged access to customer digital infrastructure, touted as a defense against AI disruption, may become less relevant as agencies adopt zero-trust architectures and cloud-native solutions that reduce reliance on legacy system integrators. Furthermore, the rising importance of AI in national security is attracting new entrants—including large tech firms and specialized AI startups—who are better positioned to innovate at the forefront of machine learning applications, potentially leapfrogging Leidos in areas like predictive maintenance or autonomous decision support where the company's current advantages in legacy system knowledge matter less. This dynamic threatens to erode Leidos' pricing power and market share in its fastest-growing segments over time, turning what management views as a propellant into a long-term competitive pressure that could force sustained investment just to maintain parity.

Segments Breakdown of Revenue (2026)

Peer Comparison

Companies in the Information Technology Services

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	IBM	International Business Machines Corp	193.88 Bn	8,812.83	2.81	61.99 Bn
2	ACN	Accenture plc	84.94 Bn	10.70	1.16	5.14 Bn
3	GDS	GDS Holdings Ltd	50.55 Bn	126.44	29.45	-
4	INFY	Infosys Ltd	44.05 Bn	0.29	0.05	-
5	GIB	Cgi Inc	41.25 Bn	0.32	3.47	2.65 Bn
6	FIS	Fidelity National Information Services, Inc.	20.63 Bn	134.81	1.80	16.99 Bn
7	CTSH	Cognizant Technology Solutions Corp	20.39 Bn	9.24	0.95	0.57 Bn
8	WIT	Wipro Ltd	18.65 Bn	12.56	1.80	1.88 Bn

Research Tools

Developers

About

Investment Thesis

Segments Breakdown of Revenue (2026)

Segments Breakdown of Revenue (2026)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Segments Breakdown of Revenue (2026)

Segments Breakdown of Revenue (2026)

Peer Comparison

Create an account

Sign In

Reset Password